Genetic Testing in Advanced Prostate Cancer
CME Available: https://auau.auanet.org/node/33260 ACKNOWLEDGEMENTS Support provided by independent educational grants from: Amgen Astellas AstraZeneca Bayer HealthCare Pharmaceuticals Inc. Exact Sciences Corporation Merck Pfizer, Inc. Sanofi Genzyme
▶︎
Maximal Androgen Targeted vs Chemohormonal Therapy for mHSPC & Management of Oligometastatic Disease
▶︎
Genetic Testing in Advanced Prostate Cancer (2026)
▶︎
Using Genetic Testing in Prostate Cancer: When and How with Dr. Alan H. Bryce, MD
▶︎
What's New in Hereditary Prostate Cancer Treatment
▶︎
Prostate Cancer Genetics and Genomics
▶︎
Evolving Strategies in the Diagnosis and Treatment of Muscle-Invasive Bladder Cancer
▶︎
Identification of High Risk Disease and Initial Management of Biochemical Recurrence
▶︎
How to Become Clinical Trial Ready, Using the Optune Gio Device for GBM/rGBM & FORTE Clinical Trial
▶︎
Prostate Cancer in 2024: Recent Updates and Treatment Advances
▶︎
Prostate Cancer Genetics 101
▶︎
CAOH 2025: Ana C Garrido Castro, MD - Assistant Professor of Medicine, Dana Farber Cancer Institute
▶︎
Role of Chemotherapy, Treatment Sequencing in mCRPC and Future Directions
▶︎
#ProstateCancer Diagnosis Over 80 Years Old | #MarkScholzMD #AlexScholz | #PCRI
▶︎
Introduction to Genomic Biomarkers in Radiation Oncology
▶︎
Prostate Cancer: What You NEED To Know
▶︎
Role of PARP Inhibitors in Prostate Cancer
▶︎
What is the ideal duration of hormone therapy for the treatment of prostate cancer?
▶︎
Genomic Testing for Prostate Cancer
▶︎
Active Surveillance & #ProstateCancer In 2024 | Laurence Klotz, MD #PCRI #2024PCRICon
▶︎